Stockreport

Cellular Biomedicine obtained NCI patent license for neoantigen-reactive TIL technology to treat  solid tumors [Seeking Alpha]

CELLULAR BIOMEDICINE GROUP INC  (CBMG) 
Last cellular biomedicine group inc earnings: 11/6 04:25 pm Check Earnings Report
US:NASDAQ Investor Relations: cellbiomedgroup.com/investor-relations
PDF Cellular Biomedicine Group (NASDAQ: CBMG ) has entered into a Patent License Agreement with the National Cancer Institute (“NCI”). Pursuant to the License Ag [Read more]